The American Association of Cancer Research speaks with James P. Allison, director of the Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center. He discusses his work at the forefront of immunotherapeutics and the development of ipilimumab, the first immunotherapy to show improved survival in patients with advanced melanoma.
Learn about MSK: [ Ссылка ]
CONNECT WITH MSK
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
Request an appointment at MSK by calling 800-525-2225 or online at: [ Ссылка ]
